Thromb Haemost 2002; 88(01): 115-122
DOI: 10.1055/s-0037-1613163
Review Article
Schattauer GmbH

Evidence that the Platelet Integrin αIIbβ3 Is Regulated by the Integrin-Linked Kinase, ILK, in a PI3-Kinase Dependent Pathway

Jean-Max Pasquet
1   UMR 5533 CNRS, Hôpital Cardiologique du Haut-Lévêque, Pessac, France
,
Malia Noury
1   UMR 5533 CNRS, Hôpital Cardiologique du Haut-Lévêque, Pessac, France
,
Alan T. Nurden
1   UMR 5533 CNRS, Hôpital Cardiologique du Haut-Lévêque, Pessac, France
› Author Affiliations
Further Information

Publication History

Received 22 January 2002

Accepted after revision 11 April 2002

Publication Date:
09 December 2017 (online)

Summary

Platelet aggregation is mediated by the integrin αIIbβ3 which is activated by intracellular signals during platelet activation. We have attempted to determine if ILK (“Integrin-Linked Kinase”) is involved in the regulation of αIIbβ3 function. ILK co-immunoprecipitated with β3 in stimulated platelets. Using confocal microscopy, ILK was detected in the cytoplasm of resting platelets. ADP or PMA stimulation led to its translocation to the plasma membrane. In parallel, there was a transient increase in ILK kinase activity, association with and phosphorylation of β3. Inhibition of PI3-kinase by two unrelated inhibitors (wortmannin and LY294002) prevented ILK-related functions. However, it did not prevent the conformational change in αIIbβ3 (shown by PAC-1 binding), although integrin affinity for fibrinogen was decreased as measured using FITC-fibrinogen. Furthermore, aggregate formation was reduced. Thus ILK transiently associates with and phosphorylates β3 in a PI3-kinase dependent manner suggesting that it participates at an intermediate stage in a critical mechanism for assuring large stable aggregates.

 
  • References

  • 1 George JN. Platelets. Lancet 2000; 355: 1531-9.
  • 2 Law DA, Nannizzi-Alaimo L, Phillips DR. Outside-in integrin signal transduction. J Biol Chem 1996; 271: 10811-5.
  • 3 Payrastre B, Missy K, Trumel C, Boddin S, Plantavid M, Chap H. The integrin alphaIIbbeta3 in human platelet signal transduction. Biochem Pharmacol 2000; 60: 1069-74.
  • 4 Knezevic I, Leisner T, Lam S. Direct binding of the platelet integrin alphaIIbbeta3 (GPIIb-IIIa) to talin. J Biol Chem 1996; 271: 16416-21.
  • 5 Pfaff M, Liu S, Erle DJ, Ginsberg MH. Integrin beta cytoplasmic domains differentially binds to cytoskeleton proteins. J Biol Chem 1998; 273: 6104-9.
  • 6 Liu S, Calderwood DA, Ginsberg MH. Integrin cytoplasmic domainbinding proteins. J Cell Sci 2000; 113: 3563-71.
  • 7 Dedhar S, Hannigan GE. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996; 08: 657-69.
  • 8 Thomas JM, Gibbins JM. The role of the integrin-linked kinase in beta-1 and beta-3 integrin-mediated adhesion of human platelets. Thromb Haemost 2001; 86 (Suppl): P2645.
  • 9 Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S. Regulation of cell adhesion and anchoragedependent growth by a new beta 1-integrin-linked protein kinase. Nature 1996; 379: 91-6.
  • 10 Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 1998; 95: 11211-6.
  • 11 Dedhar S, Williams B, Hannigan G. Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol 1999; 09: 319-23.
  • 12 Janji B, Melchior C, Vallar L, Kieffer N. Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation. Oncogene 2000; 19: 3069-77.
  • 13 Li F, Zhang Y, Wu C. Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats. J Cell Sci 1999; 112: 4589-99.
  • 14 Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 2001; 276: 27462-9.
  • 15 Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 1998; 273: 528-36.
  • 16 Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 2000; 97: 3207-12.
  • 17 Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 1997; 272: 13937-44.
  • 18 Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA 1998; 95: 4374-9.
  • 19 Novak A, Dedhar S. Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 1999; 56: 523-37.
  • 20 Leung-Hagesteijn C, Mahendra A, Naruszewicz I, Hannigan GE. Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. Embo J 2001; 20: 2160-70.
  • 21 Dachary-Prigent J, Freyssinet J-M, Pasquet J-M, Carron JC, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-65.
  • 22 Pasquet JM, Quek L, Pasquet S, Poole A, Matthews JR, Lowell C, Watson SP. Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI. J Biol Chem 2000; 275: 28526-31.
  • 23 Pasquet J, Toti F, Nurden A, Dachary-Prigent J. Procoagulant activity and active calpain in platelet-derived microparticles. Thromb Res 1996; 82: 509-22.
  • 24 Fox EJ. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884-93.
  • 25 Bobe R, Wilde JI, Maschberger P, Venkateswarlu K, Cullen PJ, Siess W, Watson SP. Phosphatidylinositol 3-kinase-dependent translocation of phospholipase Cgamma2 in mouse megakaryocytes is independent of Bruton tyrosine kinase translocation. Blood 2001; 97: 678-84.
  • 26 Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
  • 27 French DL, Seligsohn U. Platelet glycoprotein IIb/IIIa receptors and Glanzmann’s thrombasthenia. Arterioscler Thromb Vasc Biol 2000; 20: 607-10.
  • 28 Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol 1998; 08: 359-64.
  • 29 Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: The platelet paradigm. Blood 1998; 91: 2645-57.
  • 30 Woodside DG, Liu S, Ginsberg MH. Integrin activation. Thromb Haemost 2001; 86: 316-23.
  • 31 Kirk RI, Sanderson MR, Lerea KM. Threonine phosphorylation of the beta3 integrin cytoplasmic tail, at a site recognized by PDK1 and Akt/PKB in vitro, regulates Shc binding. J Biol Chem 2000; 275: 30901-6.
  • 32 Banfic H, Downes CP, Rittenhouse SE. Biphasic activation of PKBalpha/ Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 11630-7.
  • 33 Kroner C, Eybrechts K, Akkerman JW. Dual regulation of platelet protein kinase B. J Biol Chem 2000; 275: 27790-8.
  • 34 Barry FA, Gibbins JM. Protein kinase B is regulated in platelets by the collagen receptor glycoprotein VI. J Biol Chem 2002; 277 (15) 2874-8.
  • 35 Banfic H, Tang X, Batty IH, Downes CP, Chen C, Rittenhouse SE. A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets. J Biol Chem 1998; 273: 13-6.
  • 36 Hoyt CH, Lerea KM. Aggregation-dependent signaling in human platelets is sensitive to protein serine/threonine phosphatase inhibitors. Biochemistry 1995; 34: 9565-70.
  • 37 Lerea KM, Cordero KP, Sakariassen KS, Kirk RI, Fried VA. Phosphorylation sites in the integrin beta3 cytoplasmic domain in intact platelets. J Biol Chem 1999; 274: 1914-9.
  • 38 Chen Y-P, O’Toole TE, Ylänne J, Rosa J-P, Ginsberg MH. A point mutation in the integrin beta3 cytoplasmic domain (S752-P) impairs bidirectional signaling through alphaIIbbeta3 (platelet glycoprotein IIb-IIIa). Blood 1994; 84: 1857-65.
  • 39 Parise LV, Criss AB, Nannizzi L, Wardell MR. Glycoprotein IIIa is phosphorylated in intact human platelets. Blood 1990; 75: 2363-8.
  • 40 Van Willigen G, Hers I, Gorter G, Akkerman J-WN. Exposure of ligandbinding sites on platelet integrin alphaIIbbeta3 by phosphorylation of the beta3 subunit. Biochem J 1996; 314: 769-79.